The inaugural conference on Patenting and Life Sciences was held at Cold Spring Harbor Laboratory in March 2013. The conference featured IP speakers discussing issues surrounding patenting genes and diagnostics. The topic was right in time for the heated debate over Myriad’s patentability of BRCA genes, the tumor suppressor genes often found mutated in breast and ovarian cancer patients (see Association for Molecular Pathology v. Myriad Genetics). Michele was invited to speak about the importance of patenting on promoting innovations and her experience in managing complex genomic portfolios in Human Genome Sciences.
Read more about the conference: http://www.patents4life.com/2013/01/cold-spring-harbor-laboratory-conference-on-patenting-in-the-life-sciences/
